Clinical trials in T-cell lymphoma

The table below shows a list of The Lymphoma Group's current clinical trials open for recruitment for T-Cell lymphoma patients.

If you would like to know how to access our trials please click here

 

 

Trial Name

 

Description

 

Click the link for more information (external page)

 

AVAIL-T

 

A Phase 2a trial of Avelumab, an anti-PD-L1 antibody to treat peripheral T-cell lymphoma (PTCL)

Suitable for patients with lymphoma which has come back after previous treatment

 

 

 

ADCT-301

 

A phase 1 study testing a new drug, ADCT-301

Suitable for patients with lymphoma which has come back after previous treatment

 

 

 

C25006

 

Phase 4 study of Brentuximab vedotin, a CD30-targeting antibody-drug conjugate

Suitable for patients with lymphoma which has come back after previous treatment

 

 

 

RESMAIN

 

Phase 2 study testing resminostat as treatment for people with mycosis fungoides (MF) or Sézary syndrome (SS), a type of cutaneous (skin) T-cell lymphoma.

Suitable for patients who have received treatment and their lymphoma is stable or in remission

 

 

 

ROMI-CAR

 

Phase 1-2 study looking at the dosage and effectiveness of new drugs romidepsin and carfilzomib

Suitable for patients with lymphoma which has come back after previous treatment

 

 

 

PROCLIPI

 

A non-medicinal (observational) clinical trial involving collecting data on patients with mycosis fungoides (primary cutaneous T cell lymphoma) and Sézary syndrome (SS), to help determine how we manage future patients.

 

 

 

 

*Please note, we update this page fortnightly

With special thanks to the following: